A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

July 24, 2025

Study Completion Date

September 4, 2025

Conditions
Plaque Psoriasis
Interventions
DRUG

LY4100511

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (58)

1307

Universitätsklinikum Carl Gustav Carus an der TU, Dresden

3200

Gyongyosi Bugat Pal Korhaz, Gyöngyös

4032

Debreceni Egyetem Klinikai Kozpont, Debrecen

5000

Allergo-Derm Bakos Kft, Szolnok

8200

MedMare Bt, Veszprém

10100

Clintrial s.r.o., Prague

13000

Pratia Prague s.r.o. - PRATIA - PPDS, Prague

20850

Lawrence J Green, M.D, LLC, Rockville

22391

MensingDerma Research GmbH, Hamburg

33012

Direct Helpers Research Center, Hialeah

33134

Driven Research, Coral Gables

33613

ForCare Clinical Research, Tampa

34470

Renstar Medical Research, Ocala

35244

Cahaba Dermatology Skin Health Center, Birmingham

48149

Universitätsklinikum Münster, Münster

60590

Universitätsklinikum Frankfurt, Frankfurt am Main

72022

Dermatology Trial Associates, Bryant

72076

Universitätsklinikum Tübingen, Tübingen

77598

Center for Clinical Studies, LTD.LLP, Webster

86150

Praxis Dr. med. Virgil-Oreste Mihaescu Facharzt fr Dermatologie und STD, Augsburg

90045

Dermatology Research Associates, Los Angeles

90212

Zenith Research, Inc., Beverly Hills

90404

Clinical Science Institute, Santa Monica

92708

First OC Dermatology Research Inc, Fountain Valley

94538-1614

Center for Dermatology Clinical Research, Fremont

33713-8012

GCP Global Clinical Professionals, LLC, St. Petersburg

60077-1049

Endeavor Clinical Trials Center - Dermatology - Skokie, Skokie

V1W 4V5

Interior Dermatology Centre - Probity - PPDS, Kelowna

V9T1W1

Skin Care West, Nanaimo

L4M 7G1

Simcoderm Medical & Surgical Dermatology Centre, Barrie

L8N 1Y2

Dermatrials Research Inc., Hamilton

N6A 5R9

Lovegrove Dermatology - Probity - PPDS, London

N6H 5L5

DermEffects - Probity - PPDS, London

L3P 1X2

Lynderm Research Inc., Markham

L4Y 4C5

DermEdge Research, Mississauga

530 02

Pratia Pardubice a.s. - PRATIA - PPDS, Pardubice

100 34

Fakultni nemocnice Kralovske Vinohrady, Prague

160 00

Kozni ambulance Fialova, s.r.o. - CRC - PPDS, Prague

450-0003

Nagoya City University Hospital, Nagoya

060-0063

Medical Corporation Kojinkai Sapporo Skin Clinic, Sapporo

890-0063

Katahira Dermatology Urology Clinic, Kagoshima

861-4101

Ohyama Dermatology Clinic, Kumamoto

593-8324

Kume Clinic, Sakai-shi

160-0023

Tokyo Medical University Hospital, Shinjuku-ku

190-0023

Tachikawa Dermatology Clinic, Tachikawa

933-0871

Shirasaki dermatology clinic, Takaoka

Unknown

Igarashi Dermatological Clinic, Tokyo

50-381

AES - DRS - Synexus Polska Sp. z o.o. Oddzial we Wroclawiu, Wroclaw

50-566

Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak Spółka Partnerska, Wroclaw

00-710

Clinical Best Solutions, Warsaw

35-055

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie, Rzeszów

80-382

AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdansk

81-537

AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia

42-202

Synexus Polska Sp. z o.o. Oddzial w Czestochowie, Częstochowa

70-332

Laser Clinic Dermatologia Laserowa Medycyna Estetyczna, Szczecin

40-611

Centrum Medyczne Angelius Provita, Katowice

02-665

Centrum Medyczne Reuma Park NZOZ, Warsaw

90-436

Dermoklinika Centrum Medyczne s.c. M. Kierstan J. Narbutt A. Lesiak, Lodz

All Listed Sponsors
lead

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

INDUSTRY

NCT06602219 - A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter